Article Information
History
- July 22, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Stephanie Vauleon1,
- Katharina Schutz1,
- Benoit Massonnet1,
- Nanda Gruben2,
- Marianne Manchester3,
- Alessandra Buehler1,
- Eginhard Schick1,
- Lauren Boak4 and
- David J Hawellek5,*
- 1Regulated Bioanalysis, Pharmaceutical Sciences, Roche Pharmaceutical Research and Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland
- 2ICON Bioanalytical Laboratories, Assen, The Netherlands
- 3Pharmaceutical Sciences, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland
- 4F. Hoffmann-La Roche Ltd, Basel, Switzerland
- 5Biomarkers & Translational Technologies, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland
- ↵*Corresponding author:
David J Hawellek, Tel: +41 6168 2195, david.hawellek{at}roche.com, Roche, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.